Joshua Sharfstein, who recently was appointed by President Barack Obama to serve as deputy commissioner of the US Food and Drug Administration, this week took over as acting FDA commissioner.
Sharfstein will hold that title while confirmation hearings are held for Margaret Hamburg, who was named by Obama to head the agency.
He takes over the interim role from Frank Torti, who has served as acting FDA commissioner since January.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
